Related references
Note: Only part of the references are listed.A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
Cornelius Katona et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
Enric Alvarez et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
A. Mork et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Benny Bang-Andersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype
Johannes G. Ramaekers et al.
PSYCHOPHARMACOLOGY (2011)
Productivity Losses Among Treated Depressed Patients Relative to Healthy Controls
Suellen Curkendall et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2010)
Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder
I. Hindmarch
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Lu AA21004: a novel potential treatment for mood disorders
N. Moore et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance
EL Theunissen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: A crossover trial
M Wingen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo
EL Theunissen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance
F Ridout et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2003)
Antidepressants and driver impairment: Empirical evidence from a standard on-the-road test
JG Ramaekers
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Tolerability and safety aspects of mirtazapine
DJ Nutt
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)
Cognitive deficits in depression - Possible implications for functional neuropathology
MP Austin et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Share Paper
